🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Emily Jonczak

University of Miami

ORCID: 0000-0002-0983-8016

Also affiliated with University of Miami Health System, Sylvester Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Dose escalation of ripretinib can lead to response in advanced gastrointestinal stromal tumor patients refractory to the standard dose: a report of two cases”.

Dose escalation of ripretinib can lead to response in advanced gastrointestinal stromal tumor patients refractory to the standard dose: a report of two cases

Gastrointestinal Stromal Tumor(2021)10.21037/gist-21-1

N/A

0DataRank · unranked

4 citations

Caroline Hana, Navin Balaji, Anthony Frank Skryd, Brianna Nicole Valdes, Ramon O. Minjares +9 more

Pexidartinib and CSF1R Inhibitors as Treatment for Tenosynovial Giant Cell Tumors

touchREVIEWS in Oncology & Haematology(2021)10.17925/ohr.2021.16.2.119

N/A

0DataRank · unranked

2 citations

Ty K. Subhawong, Gina Z. D’Amato, Emily Jonczak, Erika Garbrecht, Sheila A. Conway +2 more

DNA Damage Repair Pathway Alterations and Immune Landscape Differences in Pediatric/Adolescent, Young Adult (AYA) and Adult Sarcomas

Cancers(2025)10.3390/cancers17121962

N/A

0DataRank · unranked

3 citations

Andrew Elliott, Steven Bialick, César Serrano, Margaret von Mehren, Matthew J. Oberley +11 more